Dud vaccines ‘unacceptable,’ senator says | Inquirer News
LOW EFFICACY RATE

Dud vaccines ‘unacceptable,’ senator says

MADE IN CHINA A doctor shows the Sinovac vaccine. —AFP

MANILA, Philippines — Sen. Juan Miguel Zubiri on Saturday urged the Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF) to rethink its plans to avail of vaccines with low efficacy rate, calling this proposition as “unacceptable.”

“We appeal to our task force leaders to look at the effectiveness of the [vaccine] rather than political or geopolitical reasons. The safety of our people should come first not the feelings of our neighboring friends,” he said.

Article continues after this advertisement

Zubiri did not mention a specific brand, but he made the remark after the IATF announced that it preferred vaccines made by Chinese pharmaceuticals Sinovac, Sinopharm, and CanSino because of their “affordability and production capability.”

FEATURED STORIES

The government also announced that it was at an advanced stage in forging a deal for the purchase of 25 million doses from Sinovac after Western drugmakers struggled to meet the demand of nations, particularly the United States, which have already paid for the vaccines even before the completion of clinical trials.

But Brazil, the first country to complete a late-stage trial of the Sinovac vaccine, said on Dec. 23 that the vaccine, called CoronaVac, was only more than 50-percent effective based on trial data.

Article continues after this advertisement

The Department of Science and Technology said CoronaVac’s 50-percent efficacy rate is “acceptable” because that was the minimum requirement of the World Health Organization.

Article continues after this advertisement

‘Waste of funds’

Zubiri acknowledged that several factors must be considered in choosing a vaccine for Filipinos, mainly safety, efficacy, pricing, and ease of distribution and implementation.

Article continues after this advertisement

But spending taxpayers’ money for vaccines that were only 50-percent effective would be a “total waste of funds and resources,” he added.

“That means there’s a 50-50 chance of you getting COVID even after being vaccinated, [which] is a joke!” he said.

Article continues after this advertisement

He said other brands, such as Pfizer, have a higher efficacy rating of 95 percent, but the country lacks storage facilities that can maintain temperatures of -70 degrees Celsius. INQ

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: CanSino, Coronavac, IATF, Sinopharm, Sinovac, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.